NCT00076531已完成3 期
Clinical Trial for Prostate Cancer
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
研究概览
简要总结
Phase III trial using an injectable for treatment of prostate cancer.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 40 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
3 期
COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate CancerProstate NeoplasmNCT03241537Samsung Medical Center61
终止
3 期
Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for RecurrenceProstate CancerNCT00003645M.D. Anderson Cancer Center64
已完成
3 期
Study of Immunotherapy to Treat Advanced Prostate CancerProstate CancerNCT00861614Bristol-Myers Squibb988
已完成
3 期
Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer PatientsProstate CancerNCT00884273Ferring Pharmaceuticals182
已完成
早期 1 期
INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological CancersMetastatic Castration-resistant Prostate Cancer (mCRPC)Metastatic Urothelial CarcinomaMetastatic Renal Cell CarcinomaNCT03071328Duke University10